Marc Boogaerts
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 31
- Chronic Myeloid Leukemia Treatments 20
- Hematopoietic Stem Cell Transplantation 19
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 16
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 12
- Epidemiology top 1%
- Fungal Infections and Studies 13
- Small Animals top 1%
-
- Lymphoma Diagnosis and Treatment 15
-
- Neutropenia and Cancer Infections 13
- Co-authors
- Johan MaertensJan VerhaegenJohan Van EldereGregor VerhoefMartin H. SteinbergJohn W. EatonRobert P. HebbelPeter Vandenberghe
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Marc Boogaerts
111 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 2.0k
- Infectious Diseases 1.8k
- Genetics 916
- Epidemiology 1.8k
- Small Animals 333
Countries citing papers authored by Marc Boogaerts
This map shows the geographic impact of Marc Boogaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Boogaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Boogaerts more than expected).
Fields of papers citing papers by Marc Boogaerts
This network shows the impact of papers produced by Marc Boogaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Boogaerts. The network helps show where Marc Boogaerts may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc Boogaerts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 141 | |
| 2 | 5-aza-2 '-deoxycytidine can induce differentiation of clonal abnormal progenitor cells from patients with myelodysplastic syndromes without induction of apoptosis | 2008 | 4 |
| 3 | Apoptosis levels of CD34+cells after induced DNA damage: Measurement of DNA fragmentation in different annexin V-affinity fractions of sorted CD34+cells using the DNA diffusion assay and comet assay | 2007 | 1 |
| 4 | Transplantation of autologous bone marrow-derived stem cells in patients with ST-segment elevation myocardial infarction | 2005 | 0 |
| 5 | 2001 | 298 | |
| 6 | Reduced expression of alpha 5 beta 1 integrins on CD34(+) marrow progenitors of MDS patients with high levels of apoptosis | 2000 | 1 |
| 7 | 1999 | 3 | |
| 8 | Itraconazole (IT) compared with amphotericin B (AMB) as empirical therapy for persistent fever of unknown origin (FUO) in neutropenic patients (PTS) | 1999 | 9 |
| 9 | Intensive non-myeloablative chemotherapy can induce GvHD and complete remission in patients with AML/MDS relapsing after allo-BMT | 1998 | 1 |
| 10 | Application of the international scoring system (IPSS) for myelodysplastic syndromes (MDS) | 1998 | 1 |
| 11 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) fails to improve outcome in invasive fungal infections in neutropenic cancer patients | 1996 | 1 |
| 12 | FISH characterization of two new meyloid breakpoints in t(11;21)(q24;q11.2) translocaton associated wit Myelodysplastic Syndromes (MDS) | 1996 | 2 |
| 13 | Comparison of whole-body positron emission tomography and Gallium-67 citrate imaging for staging of lymphoma | 1996 | 2 |
| 14 | Intensive chemotherapy followed by autologous progenitor cell transplantation may lead to prolonged hematological and molecular remission in chronic lymphocytic leukemia (CLL) | 1996 | 1 |
| 15 | 1996 | 27 | |
| 16 | 1996 | 28 | |
| 17 | CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial | 1995 | 1 |
| 18 | 1994 | 9 | |
| 19 | 1993 | 21 | |
| 20 | Bone marrow transplantation in a patient with secondary leukemia | 1982 | 24 |
About Marc Boogaerts
Marc Boogaerts is a scholar working on Hematology, Genetics and Oncology, having authored 115 papers that have together received 5.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (31 papers), Chronic Myeloid Leukemia Treatments (20 papers), Hematopoietic Stem Cell Transplantation (19 papers), Antifungal resistance and susceptibility (16 papers), Lymphoma Diagnosis and Treatment (15 papers), Neutropenia and Cancer Infections (13 papers), Fungal Infections and Studies (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Hematology (2.0k citations), Infectious Diseases (1.8k citations) and Genetics (916 citations). Marc Boogaerts has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Johan Maertens, Jan Verhaegen, Johan Van Eldere, Gregor Verhoef, Martin H. Steinberg, John W. Eaton, Robert P. Hebbel, Peter Vandenberghe, Katrien Lagrou and Leo F. Verdonck. Their work appears in journals such as New England Journal of Medicine, Circulation and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.